Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Devissaguet

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Fundamental & Clinical Pharmacology|January 1, 1990
Pharmacokinetics of perindopril and its metabolites in healthy volunteersJ P Devissaguet, N Ammoury, M Devissaguet, et al.
Biomaterials|February 1, 1997
Influence of sterilization processes on poly(epsilon-caprolactone) nanospheresV Masson, F Maurin, H Fessi, et al.
Life Sciences|March 7, 1998
Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement systemC Passirani, G Barratt, J P Devissaguet, et al.
American Journal of Nephrology|January 1, 1986
Biodisposition of tertatolol in man: a reviewD B Campbell, J C Chignon, J P Devissaguet
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulationsJ P Devissaguet, N Brion, O Lhote, et al.
Therapie|November 1, 1979
[Bioavailability of two quinidin drug-released products (author's transl)]P A Sado, R Le Verge, J P Devissaguet
Annales Pharmaceutiques Francaises|January 1, 1978
[Pharmaceutical investigations on acetyl salicylic acid. Study of "in vito" dissolution of commercial forms. Application of the results obtained to analogue computer simulation (author's transl)]P A Sado, R Le Verge, J P Devissaguet
Journal De Pharmacie De Belgique|January 1, 1985
[Clometacin. IV. Research of a fast-acting oral pharmaceutic form; galenic and pharmacokinetic studies in animals]B Hercelin, I Mary, V N Nung, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing miceN Chiannilkulchai, N Ammoury, B Caillou, et al.
Journal of Medicinal Chemistry|October 25, 1996
Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivativesG Merhi, A W Coleman, J P Devissaguet, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Fundamental & Clinical Pharmacology|January 1, 1990
Pharmacokinetics of perindopril and its metabolites in healthy volunteersJ P Devissaguet, N Ammoury, M Devissaguet, et al.
Biomaterials|February 1, 1997
Influence of sterilization processes on poly(epsilon-caprolactone) nanospheresV Masson, F Maurin, H Fessi, et al.
Life Sciences|March 7, 1998
Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement systemC Passirani, G Barratt, J P Devissaguet, et al.
American Journal of Nephrology|January 1, 1986
Biodisposition of tertatolol in man: a reviewD B Campbell, J C Chignon, J P Devissaguet
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulationsJ P Devissaguet, N Brion, O Lhote, et al.
Therapie|November 1, 1979
[Bioavailability of two quinidin drug-released products (author's transl)]P A Sado, R Le Verge, J P Devissaguet
Annales Pharmaceutiques Francaises|January 1, 1978
[Pharmaceutical investigations on acetyl salicylic acid. Study of "in vito" dissolution of commercial forms. Application of the results obtained to analogue computer simulation (author's transl)]P A Sado, R Le Verge, J P Devissaguet
Journal De Pharmacie De Belgique|January 1, 1985
[Clometacin. IV. Research of a fast-acting oral pharmaceutic form; galenic and pharmacokinetic studies in animals]B Hercelin, I Mary, V N Nung, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing miceN Chiannilkulchai, N Ammoury, B Caillou, et al.
Journal of Medicinal Chemistry|October 25, 1996
Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivativesG Merhi, A W Coleman, J P Devissaguet, et al.
Pageof 6